News
Sarepta's therapy has been under scrutiny from regulators after two teenage boys died earlier this year from acute liver ...
47m
Asianet Newsable on MSNWhy Sarepta Therapeutics Stock Surged Nearly 48% In After-Hours Trading TodayThe FDA concluded that a recent patient death in Brazil was unrelated to Sarepta’s Elevidys treatment, allowing the company ...
19m
Stockhead on MSNHealth Check: A ‘manageable headwind’ as Trump slugs Europe with 15pc pharma tariffEuropean pharma companies are breathing a sigh of relief after the Trump administration posed a 15pc tariff, rather than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results